当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析 - 现金流量表

万孚生物

(300482)

  

流通市值:94.30亿  总市值:102.56亿
流通股本:4.30亿   总股本:4.68亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,134,980,629.79545,604,909.142,524,764,937.671,873,408,724.1
  收到的税费返还2,906,654.652,582,976.597,590,139.47,160,532.84
  收到其他与经营活动有关的现金16,577,305.58,911,951.668,875,787.9168,439,237.69
  经营活动现金流入小计1,154,464,589.94557,099,837.332,601,230,864.981,949,008,494.63
  购买商品、接受劳务支付的现金368,579,617.19216,428,689.88759,546,414.37597,781,929.5
  支付给职工以及为职工支付的现金470,194,564.38275,537,794.11839,046,665.47626,141,559.34
  支付的各项税费104,803,315.7156,549,810.21151,160,129.66129,012,944.59
  支付其他与经营活动有关的现金267,198,543.92157,371,262.71489,766,524.62422,748,781.06
  经营活动现金流出小计1,210,776,041.2705,887,556.912,239,519,734.121,775,685,214.49
  经营活动产生的现金流量净额-56,311,451.26-148,787,719.58361,711,130.86173,323,280.14
二、投资活动产生的现金流量:
  收回投资收到的现金2,543,601,533.851,258,166,2904,464,663,782.882,919,474,526.47
  取得投资收益收到的现金27,479,777.4510,004,989.8556,972,170.7232,972,517.09
  处置固定资产、无形资产和其他长期资产收回的现金净额31,083.1131,083.1157,684.8-
  处置子公司及其他营业单位收到的现金净额1,499,349.59---
  投资活动现金流入小计2,572,611,7441,268,202,362.964,521,693,638.42,952,447,043.56
  购建固定资产、无形资产和其他长期资产支付的现金117,590,146.7764,073,785.12318,212,841.8292,378,883.67
  投资支付的现金2,659,312,987.191,579,825,304.455,209,641,722.854,053,320,437.3
  取得子公司及其他营业单位支付的现金--10,435,750-
  投资活动现金流出小计2,776,903,133.961,643,899,089.575,538,290,314.654,345,699,320.97
  投资活动产生的现金流量净额-204,291,389.96-375,696,726.61-1,016,596,676.25-1,393,252,277.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金--864,083,358.1864,083,358.1
  收到其他与筹资活动有关的现金3,134,503.782,386,986.9519,281,400.344,071,118.46
  筹资活动现金流入小计3,134,503.782,386,986.95883,364,758.44868,154,476.56
  偿还债务支付的现金--1,303.52-
  分配股利、利润或偿付利息支付的现金192,569,904.4-202,287,347.7202,873,508.81
  其中:子公司支付给少数股东的股利、利润--6,125,0006,125,000
  支付其他与筹资活动有关的现金37,770,015.31160,00041,998,182.5720,503,025.41
  筹资活动现金流出小计230,339,919.71160,000244,286,833.79223,376,534.22
  筹资活动产生的现金流量净额-227,205,415.932,226,986.95639,077,924.65644,777,942.34
四、汇率变动对现金及现金等价物的影响635,699.82237,482.294,332,842.78-850,686.9
五、现金及现金等价物净增加额-487,172,557.33-522,019,976.95-11,474,777.96-576,001,741.83
  加:期初现金及现金等价物余额828,103,028.65828,103,028.65839,577,806.61839,577,806.61
  期末现金及现金等价物余额340,930,471.32306,083,051.7828,103,028.65263,576,064.78
补充资料:
  净利润190,209,871.9-565,215,133.8-
  资产减值准备6,179,297.87-51,166,765.51-
  固定资产和投资性房地产折旧106,893,827.42-205,013,492.83-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧106,893,827.42-205,013,492.83-
  无形资产摊销18,115,759.43-44,457,105.41-
  长期待摊费用摊销1,787,510.77-4,196,264.69-
  处置固定资产、无形资产和其他长期资产的损失2,089.9--759,635.83-
  固定资产报废损失2,275,023.46-5,961,023.73-
  公允价值变动损失-17,604,203.48--29,617,794.26-
  财务费用15,249,638.48-16,388,173.47-
  投资损失-9,519,032.06--1,920,270.34-
  递延所得税-5,608,598.36--24,170,139.85-
  其中:递延所得税资产减少1,868,865.18--18,703,326.54-
    递延所得税负债增加-7,477,463.54--5,466,813.31-
  存货的减少17,832,234.34--12,225,971.59-
  经营性应收项目的减少-175,342,738.61--571,452,084.97-
  经营性应付项目的增加-209,687,161.13-87,044,786.76-
  其他0--421,728.42-
  债务转为资本--0-
  一年内到期的可转换公司债券--0-
  融资租入固定资产--19,570,787.42-
  现金的期末余额340,930,471.32-828,103,028.65-
  减:现金的期初余额828,103,028.65-839,577,806.61-
  加:现金等价物的期末余额--0-
  减:现金等价物的期初余额--0-
  现金及现金等价物的净增加额-487,172,557.33--11,474,777.96-
公告日期2025-08-202025-04-252025-04-102024-10-25
审计意见(境内)标准无保留意见
TOP↑